rs61734789
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001101426.4(CRPPA):c.407C>T(p.Ala136Val) variant causes a missense change. The variant allele was found at a frequency of 0.0365 in 1,613,930 control chromosomes in the GnomAD database, including 1,333 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001101426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.407C>T | p.Ala136Val | missense_variant | Exon 2 of 10 | ENST00000407010.7 | NP_001094896.1 | |
CRPPA | NM_001368197.1 | c.407C>T | p.Ala136Val | missense_variant | Exon 2 of 9 | NP_001355126.1 | ||
CRPPA | NM_001101417.4 | c.407C>T | p.Ala136Val | missense_variant | Exon 2 of 9 | NP_001094887.1 | ||
CRPPA | NR_160656.1 | n.623C>T | non_coding_transcript_exon_variant | Exon 2 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0240 AC: 3657AN: 152190Hom.: 59 Cov.: 33
GnomAD3 exomes AF: 0.0232 AC: 5776AN: 249146Hom.: 92 AF XY: 0.0239 AC XY: 3229AN XY: 135164
GnomAD4 exome AF: 0.0378 AC: 55266AN: 1461622Hom.: 1274 Cov.: 33 AF XY: 0.0367 AC XY: 26681AN XY: 727106
GnomAD4 genome AF: 0.0240 AC: 3654AN: 152308Hom.: 59 Cov.: 33 AF XY: 0.0228 AC XY: 1700AN XY: 74468
ClinVar
Submissions by phenotype
not specified Benign:5
p.Ala136Val in exon 2 of ISPD: This variant is not expected to have clinical sig nificance because it has been identified in 3.5% (290/8230) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs61734789). -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Benign:1
- -
Congenital Muscular Dystrophy, alpha-dystroglycan related Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at